Etopophos 100 lyophilized powder for injectable solution

Etopophos (E.R. Squibb & Sons, L.L.C.), manufactured drug form of Etoposide phosphate, 100mg etoposide phosphate lyophilized powder for injectable solution, NDC 0015-3404

Available in:

NDC Product ID:

  • 0015-3404

Manufacturer:

Manufactured drug form

Manufactured form of:

Generic drug:

  • No

Label date:

  • Mar 17, 2011

Label link:

Label sections:

Section name Section URI Prominent warning Highlight text Section LOINC code
  • Warnings
  • Yes
  • ETOPOPHOS ® (etoposide phosphate) for Injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Severe myelosuppression with resulting infection or bleeding may occur.
  • 34066-1
  • Description
  • No
  • 34089-3
  • Clinical Pharmacology
  • No
  • 34090-1
  • Indications And Usage
  • No
  • 34067-9
  • Contraindications
  • No
  • 34070-3
  • Warnings
  • No
  • 34071-1
  • Precautions
  • No
  • 42232-9
  • Adverse Reactions
  • No
  • 34084-4
  • Overdosage
  • No
  • 34088-5
  • Dosage And Administration
  • No
  • 34068-7
View entire collection »

Discontinued:

  • No

Marketing start date:

  • Jun 1, 2009

FDA application number:

  • NDA020457
top ↑

Consumer product

Brand:

top ↑

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!